Научные статьиM.H.Sayidova, S.U.Pulatova2025
PRIMARY PREVENTION OF ISHCEMIC HEART DISEASES
Xalilov Azizjon Marufjonovich
Академические исследования в современной науке · 3 · 164-168 · 2026
Аннотация
Although there has been substantial improvement in atherosclerotic cardiovascular disease (ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and mortality globally. Ischemic heart diseases is a constellation of disorders in which myocardial ischemia is the common pathophysiologic mechanism. In the vast majority of cases, this ischemia results from obstruction of coronary artery blood flow by atherosclerosis, but its severity and consequences are affected by other factors that affect myocardial oxygen demand (e.g., concurrent valvular disease, chronic hypertension, blood oxygenation, microvascular disease. Key words: political, economic, social factors, atherosclerotic vascular disease, heart failure, healthy diet. Ischaemic heart disease has a multifactorial etiology and can be prevented from developing in populations primordially, and in individuals at high risk by primary prevention. The primordial approach focuses on social determinants of health in populations: political, economic, and social factors, principally unplanned urbanisation, illiteracy, poverty, and working and living conditions. Implementation of the UN Sustainable Development Goals can lead to major improvements in cardiovascular health, and adequate health-care financing and universal health care are important for achieving these goals. 1. The most important way to prevent atherosclerotic vascular disease, heart failure, and atrial fibrillation is to promote a healthy lifestyle throughout life. 2. A team-based care approach is an effective strategy for the prevention of cardiovascular disease. Clinicians should evaluate the social determinants of health that affect individuals to inform treatment decisions. 3.Adults who are 40 to 75 years of age and are being evaluated for cardiovascular disease prevention should undergo 10-year atherosclerotic cardiovascular disease (ASCVD) risk estimation and have a clinician–patient risk discussion before starting on pharmacological therapy, such as antihypertensive therapy, a statin, or aspirin. The presence or absence of additional risk- enhancing factors can help guide decisions about preventive interventions in select individuals, as can coronary artery calcium scanning. 148 ACADEMIC RESEARCH IN MODERN SCIENCE International scientific-online conference 4.All adults should consume a healthy diet that emphasizes the intake of vegetables, fruits, nuts, whole grains, lean vegetable or animal protein, and fish and minimizes the intake of trans fats, red meat and processed red meats, refined carbohydrates, and sweetened beverages. For adults with overweight and obesity, counseling and caloric restriction are recommended for achieving and maintaining weight loss. 5. Adults should engage in at least 150 minutes per week of accumulated moderate-intensity physical activity or 75 minutes per week of vigorous- intensity physical activity. 6. For adults with type 2 diabetes mellitus, lifestyle changes, such as improving dietary habits and achieving exercise recommendations are crucial. If medication is indicated, metformin is first-line therapy, followed by consideration of a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist. 7. All adults should be assessed at every healthcare visit for tobacco use, and those who use tobacco should be assisted and strongly advised to quit. 8. Aspirin should be used infrequently in the routine primary prevention of ASCVD because of lack of net benefit. 9. Statin therapy is first-line treatment for primary prevention of ASCVD in patients with elevated low-density lipoprotein cholesterol levels (≥190 mg/dL), those with diabetes mellitus, who are 40 to 75 years of age, and those determined to be at sufficient ASCVD risk after a clinician–patient risk
Доказательный фрагмент
«Although there has been substantial improvement in atherosclerotic cardiovascular disease (ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and mortality globally.»
Образец извлечения
Демо-превьюAlthough there has been substantial improvement in atherosclerotic cardiovascular disease (ASCVD) outcomes in recent decades, ASCVD remains the leading cause of morbidity and mortality globally. Полный текст публикации CiteX не хранит — доступ к первоисточнику открывается по DOI согласно лицензии издателя и выбранному плану.
- Цитирований
- 0
- Тип
- Журнал
- Страна
- Узбекистан
- Ключевые слова
- political, economic, social factors, atherosclerotic vascular, atherosclerotic vascular disease, heart failure, healthy diet.
Смежные источники
Общество и инновацииKhosiyat MAMATKULOVA2024
МонографииK.J.Murodov2026
Научные статьиI.B.Yangiboyev, E.X.Berdanov +22025